| # | Drug | Count |
|---|---|---|
| 0 | SORAFENIB | 391 |
| 1 | FUROSEMIDE | 181 |
| 2 | SPIRONOLACTONE | 159 |
| 3 | URSODIOL | 120 |
| 4 | ENTECAVIR | 107 |
| 5 | RIBAVIRIN | 84 |
| 6 | ASPIRIN | 83 |
| 7 | ASPIRIN 325 MG | 83 |
| 8 | ASPIRIN 81 MG | 83 |
| 9 | PEGINTERFERON ALFA-2A | 79 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SORAFENIB | 391 | 0.0189 |
| 1 | NITISINONE | 16 | 0.0167 |
| 2 | ENTECAVIR | 107 | 0.0091 |
| 3 | FLUTAMIDE | 6 | 0.0061 |
| 4 | URSODIOL | 120 | 0.0054 |
| 5 | COAGULATION FACTOR VIIA (RECOMBINANT) | 7 | 0.0026 |
| 6 | ALBUMIN HUMAN | 11 | 0.0022 |
| 7 | ALBUMIN (HUMAN) | 11 | 0.0020 |
| 8 | 1168 BURN SPRAY | 6 | 0.0020 |
| 9 | ALLANTOIN | 6 | 0.0018 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 397 |
| 1 | Loop Diuretic [EPC] | 191 |
| 2 | Aldosterone Antagonist [EPC] | 161 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 144 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 122 |
| 5 | Bile Acid [EPC] | 120 |
| 6 | Corticosteroid [EPC] | 98 |
| 7 | Proton Pump Inhibitor [EPC] | 98 |
| 8 | Nucleoside Analog Antiviral [EPC] | 84 |
| 9 | Platelet Aggregation Inhibitor [EPC] | 84 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] | 16 | 0.0194 |
| 1 | Bile Acid [EPC] | 120 | 0.0052 |
| 2 | Vasopressin Receptor Agonist [EPC] | 1 | 0.0030 |
| 3 | Tricyclic Antidepressant [EPC] | 1 | 0.0021 |
| 4 | 5-Lipoxygenase Inhibitor [EPC] | 1 | 0.0015 |
| 5 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 9 | 0.0012 |
| 6 | Benzodiazepine Antagonist [EPC] | 1 | 0.0011 |
| 7 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 54 | 0.0011 |
| 8 | Aldosterone Antagonist [EPC] | 161 | 0.0010 |
| 9 | Photoenhancer [EPC] | 4 | 0.0010 |